カテゴリ： 世界, 医療/バイオ, QYResearch

急性リンパ芽球検査の世界市場2023年：Bリンパ球検査、Tリンパ球検査、その他

■ 英語タイトル：Global Acute Lymphoblastic Testing Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7418）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7418
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：88
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[急性リンパ芽球検査の世界市場2023年：Bリンパ球検査、Tリンパ球検査、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は急性リンパ芽球検査のグローバル市場について調査・分析し、世界の急性リンパ芽球検査市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（Bリンパ球検査、Tリンパ球検査、その他）、用途別セグメント分析（臨床検査室、病院、学術・研究機関、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、DrLal Path Labs、Bio-Rad Lab、Qiagen、Invivoscribe、Illumina、ArcherDx、Asuragen、Adaptive Biotechnologies、NeoGenomics Lab、Laboratory Corporation of America Holdings、ARUP Labなどが含まれています。急性リンパ芽球検査のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、急性リンパ芽球検査市場規模を算出する際に考慮しました。

・急性リンパ芽球検査市場の概要
- 急性リンパ芽球検査の種類別セグメント
- 世界の急性リンパ芽球検査市場規模：タイプ別分析（Bリンパ球検査、Tリンパ球検査、その他）
- 急性リンパ芽球検査の用途別セグメント
- 世界の急性リンパ芽球検査市場規模：用途別分析（臨床検査室、病院、学術・研究機関、その他）
- 世界の急性リンパ芽球検査市場規模予測（2018年-2029年）

・急性リンパ芽球検査市場の成長トレンド
- 急性リンパ芽球検査の地域別市場規模（2018年-2029年）
- 急性リンパ芽球検査市場ダイナミクス
- 急性リンパ芽球検査の業界動向
- 急性リンパ芽球検査市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：Bリンパ球検査、Tリンパ球検査、その他
- 世界の急性リンパ芽球検査のタイプ別市場規模（2018年-2023年）
- 世界の急性リンパ芽球検査のタイプ別市場規模（2024年-2029年）

・用途別セグメント：臨床検査室、病院、学術・研究機関、その他
- 世界の急性リンパ芽球検査の用途別市場規模（2018年-2023年）
- 世界の急性リンパ芽球検査の用途別市場規模（2024年-2029年）

・急性リンパ芽球検査の地域別市場規模
- 北米の急性リンパ芽球検査市場規模（2018年-2029年）
- 米国の急性リンパ芽球検査市場規模（2018年-2029年）
- ヨーロッパの急性リンパ芽球検査市場規模（2018年-2029年）
- アジア太平洋の急性リンパ芽球検査市場規模（2018年-2029年）
- 中国の急性リンパ芽球検査市場規模（2018年-2029年）
- 日本の急性リンパ芽球検査市場規模（2018年-2029年）
- 韓国の急性リンパ芽球検査市場規模（2018年-2029年）
- インドの急性リンパ芽球検査市場規模（2018年-2029年）
- オーストラリアの急性リンパ芽球検査市場規模（2018年-2029年）
- 中南米の急性リンパ芽球検査市場規模（2018年-2029年）
- 中東・アフリカの急性リンパ芽球検査市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
DrLal Path Labs、Bio-Rad Lab、Qiagen、Invivoscribe、Illumina、ArcherDx、Asuragen、Adaptive Biotechnologies、NeoGenomics Lab、Laboratory Corporation of America Holdings、ARUP Lab

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Acute Lymphoblastic Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Acute Lymphoblastic Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Acute Lymphoblastic Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Acute Lymphoblastic Testing in Clinical Laboratories is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Acute Lymphoblastic Testing include DrLal Path Labs, Bio-Rad Lab, Qiagen, Invivoscribe, Illumina, ArcherDx, Asuragen, Adaptive Biotechnologies and NeoGenomics Lab, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Acute Lymphoblastic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Lymphoblastic Testing.
The Acute Lymphoblastic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Acute Lymphoblastic Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acute Lymphoblastic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
DrLal Path Labs
Bio-Rad Lab
Qiagen
Invivoscribe
Illumina
ArcherDx
Asuragen
Adaptive Biotechnologies
NeoGenomics Lab
Laboratory Corporation of America Holdings
ARUP Lab
Segment by Type
B lymphocytes Testing
T lymphocyte Testing
Others
Segment by Application
Clinical Laboratories
Hospitals
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acute Lymphoblastic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Lymphoblastic Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 B lymphocytes Testing
1.2.3 T lymphocyte Testing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Acute Lymphoblastic Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinical Laboratories
1.3.3 Hospitals
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Lymphoblastic Testing Market Perspective (2018-2029)
2.2 Acute Lymphoblastic Testing Growth Trends by Region
2.2.1 Global Acute Lymphoblastic Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Acute Lymphoblastic Testing Historic Market Size by Region (2018-2023)
2.2.3 Acute Lymphoblastic Testing Forecasted Market Size by Region (2024-2029)
2.3 Acute Lymphoblastic Testing Market Dynamics
2.3.1 Acute Lymphoblastic Testing Industry Trends
2.3.2 Acute Lymphoblastic Testing Market Drivers
2.3.3 Acute Lymphoblastic Testing Market Challenges
2.3.4 Acute Lymphoblastic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Lymphoblastic Testing Players by Revenue
3.1.1 Global Top Acute Lymphoblastic Testing Players by Revenue (2018-2023)
3.1.2 Global Acute Lymphoblastic Testing Revenue Market Share by Players (2018-2023)
3.2 Global Acute Lymphoblastic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Lymphoblastic Testing Revenue
3.4 Global Acute Lymphoblastic Testing Market Concentration Ratio
3.4.1 Global Acute Lymphoblastic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Lymphoblastic Testing Revenue in 2022
3.5 Acute Lymphoblastic Testing Key Players Head office and Area Served
3.6 Key Players Acute Lymphoblastic Testing Product Solution and Service
3.7 Date of Enter into Acute Lymphoblastic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Lymphoblastic Testing Breakdown Data by Type
4.1 Global Acute Lymphoblastic Testing Historic Market Size by Type (2018-2023)
4.2 Global Acute Lymphoblastic Testing Forecasted Market Size by Type (2024-2029)
5 Acute Lymphoblastic Testing Breakdown Data by Application
5.1 Global Acute Lymphoblastic Testing Historic Market Size by Application (2018-2023)
5.2 Global Acute Lymphoblastic Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Acute Lymphoblastic Testing Market Size (2018-2029)
6.2 North America Acute Lymphoblastic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Acute Lymphoblastic Testing Market Size by Country (2018-2023)
6.4 North America Acute Lymphoblastic Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Lymphoblastic Testing Market Size (2018-2029)
7.2 Europe Acute Lymphoblastic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Acute Lymphoblastic Testing Market Size by Country (2018-2023)
7.4 Europe Acute Lymphoblastic Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Lymphoblastic Testing Market Size (2018-2029)
8.2 Asia-Pacific Acute Lymphoblastic Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Acute Lymphoblastic Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Acute Lymphoblastic Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Lymphoblastic Testing Market Size (2018-2029)
9.2 Latin America Acute Lymphoblastic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Acute Lymphoblastic Testing Market Size by Country (2018-2023)
9.4 Latin America Acute Lymphoblastic Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Lymphoblastic Testing Market Size (2018-2029)
10.2 Middle East & Africa Acute Lymphoblastic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Acute Lymphoblastic Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Acute Lymphoblastic Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 DrLal Path Labs
11.1.1 DrLal Path Labs Company Detail
11.1.2 DrLal Path Labs Business Overview
11.1.3 DrLal Path Labs Acute Lymphoblastic Testing Introduction
11.1.4 DrLal Path Labs Revenue in Acute Lymphoblastic Testing Business (2018-2023)
11.1.5 DrLal Path Labs Recent Development
11.2 Bio-Rad Lab
11.2.1 Bio-Rad Lab Company Detail
11.2.2 Bio-Rad Lab Business Overview
11.2.3 Bio-Rad Lab Acute Lymphoblastic Testing Introduction
11.2.4 Bio-Rad Lab Revenue in Acute Lymphoblastic Testing Business (2018-2023)
11.2.5 Bio-Rad Lab Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Detail
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Acute Lymphoblastic Testing Introduction
11.3.4 Qiagen Revenue in Acute Lymphoblastic Testing Business (2018-2023)
11.3.5 Qiagen Recent Development
11.4 Invivoscribe
11.4.1 Invivoscribe Company Detail
11.4.2 Invivoscribe Business Overview
11.4.3 Invivoscribe Acute Lymphoblastic Testing Introduction
11.4.4 Invivoscribe Revenue in Acute Lymphoblastic Testing Business (2018-2023)
11.4.5 Invivoscribe Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina Acute Lymphoblastic Testing Introduction
11.5.4 Illumina Revenue in Acute Lymphoblastic Testing Business (2018-2023)
11.5.5 Illumina Recent Development
11.6 ArcherDx
11.6.1 ArcherDx Company Detail
11.6.2 ArcherDx Business Overview
11.6.3 ArcherDx Acute Lymphoblastic Testing Introduction
11.6.4 ArcherDx Revenue in Acute Lymphoblastic Testing Business (2018-2023)
11.6.5 ArcherDx Recent Development
11.7 Asuragen
11.7.1 Asuragen Company Detail
11.7.2 Asuragen Business Overview
11.7.3 Asuragen Acute Lymphoblastic Testing Introduction
11.7.4 Asuragen Revenue in Acute Lymphoblastic Testing Business (2018-2023)
11.7.5 Asuragen Recent Development
11.8 Adaptive Biotechnologies
11.8.1 Adaptive Biotechnologies Company Detail
11.8.2 Adaptive Biotechnologies Business Overview
11.8.3 Adaptive Biotechnologies Acute Lymphoblastic Testing Introduction
11.8.4 Adaptive Biotechnologies Revenue in Acute Lymphoblastic Testing Business (2018-2023)
11.8.5 Adaptive Biotechnologies Recent Development
11.9 NeoGenomics Lab
11.9.1 NeoGenomics Lab Company Detail
11.9.2 NeoGenomics Lab Business Overview
11.9.3 NeoGenomics Lab Acute Lymphoblastic Testing Introduction
11.9.4 NeoGenomics Lab Revenue in Acute Lymphoblastic Testing Business (2018-2023)
11.9.5 NeoGenomics Lab Recent Development
11.10 Laboratory Corporation of America Holdings
11.10.1 Laboratory Corporation of America Holdings Company Detail
11.10.2 Laboratory Corporation of America Holdings Business Overview
11.10.3 Laboratory Corporation of America Holdings Acute Lymphoblastic Testing Introduction
11.10.4 Laboratory Corporation of America Holdings Revenue in Acute Lymphoblastic Testing Business (2018-2023)
11.10.5 Laboratory Corporation of America Holdings Recent Development
11.11 ARUP Lab
11.11.1 ARUP Lab Company Detail
11.11.2 ARUP Lab Business Overview
11.11.3 ARUP Lab Acute Lymphoblastic Testing Introduction
11.11.4 ARUP Lab Revenue in Acute Lymphoblastic Testing Business (2018-2023)
11.11.5 ARUP Lab Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Lymphoblastic Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of B lymphocytes Testing
Table 3. Key Players of T lymphocyte Testing
Table 4. Key Players of Others
Table 5. Global Acute Lymphoblastic Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Acute Lymphoblastic Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Acute Lymphoblastic Testing Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Acute Lymphoblastic Testing Market Share by Region (2018-2023)
Table 9. Global Acute Lymphoblastic Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Acute Lymphoblastic Testing Market Share by Region (2024-2029)
Table 11. Acute Lymphoblastic Testing Market Trends
Table 12. Acute Lymphoblastic Testing Market Drivers
Table 13. Acute Lymphoblastic Testing Market Challenges
Table 14. Acute Lymphoblastic Testing Market Restraints
Table 15. Global Acute Lymphoblastic Testing Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Acute Lymphoblastic Testing Market Share by Players (2018-2023)
Table 17. Global Top Acute Lymphoblastic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Lymphoblastic Testing as of 2022)
Table 18. Ranking of Global Top Acute Lymphoblastic Testing Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Acute Lymphoblastic Testing Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Acute Lymphoblastic Testing Product Solution and Service
Table 22. Date of Enter into Acute Lymphoblastic Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute Lymphoblastic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Acute Lymphoblastic Testing Revenue Market Share by Type (2018-2023)
Table 26. Global Acute Lymphoblastic Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Acute Lymphoblastic Testing Revenue Market Share by Type (2024-2029)
Table 28. Global Acute Lymphoblastic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Acute Lymphoblastic Testing Revenue Market Share by Application (2018-2023)
Table 30. Global Acute Lymphoblastic Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Acute Lymphoblastic Testing Revenue Market Share by Application (2024-2029)
Table 32. North America Acute Lymphoblastic Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Acute Lymphoblastic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Acute Lymphoblastic Testing Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Acute Lymphoblastic Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Acute Lymphoblastic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Acute Lymphoblastic Testing Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Acute Lymphoblastic Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Acute Lymphoblastic Testing Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Acute Lymphoblastic Testing Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Acute Lymphoblastic Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Acute Lymphoblastic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Acute Lymphoblastic Testing Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Acute Lymphoblastic Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Acute Lymphoblastic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Acute Lymphoblastic Testing Market Size by Country (2024-2029) & (US$ Million)
Table 47. DrLal Path Labs Company Detail
Table 48. DrLal Path Labs Business Overview
Table 49. DrLal Path Labs Acute Lymphoblastic Testing Product
Table 50. DrLal Path Labs Revenue in Acute Lymphoblastic Testing Business (2018-2023) & (US$ Million)
Table 51. DrLal Path Labs Recent Development
Table 52. Bio-Rad Lab Company Detail
Table 53. Bio-Rad Lab Business Overview
Table 54. Bio-Rad Lab Acute Lymphoblastic Testing Product
Table 55. Bio-Rad Lab Revenue in Acute Lymphoblastic Testing Business (2018-2023) & (US$ Million)
Table 56. Bio-Rad Lab Recent Development
Table 57. Qiagen Company Detail
Table 58. Qiagen Business Overview
Table 59. Qiagen Acute Lymphoblastic Testing Product
Table 60. Qiagen Revenue in Acute Lymphoblastic Testing Business (2018-2023) & (US$ Million)
Table 61. Qiagen Recent Development
Table 62. Invivoscribe Company Detail
Table 63. Invivoscribe Business Overview
Table 64. Invivoscribe Acute Lymphoblastic Testing Product
Table 65. Invivoscribe Revenue in Acute Lymphoblastic Testing Business (2018-2023) & (US$ Million)
Table 66. Invivoscribe Recent Development
Table 67. Illumina Company Detail
Table 68. Illumina Business Overview
Table 69. Illumina Acute Lymphoblastic Testing Product
Table 70. Illumina Revenue in Acute Lymphoblastic Testing Business (2018-2023) & (US$ Million)
Table 71. Illumina Recent Development
Table 72. ArcherDx Company Detail
Table 73. ArcherDx Business Overview
Table 74. ArcherDx Acute Lymphoblastic Testing Product
Table 75. ArcherDx Revenue in Acute Lymphoblastic Testing Business (2018-2023) & (US$ Million)
Table 76. ArcherDx Recent Development
Table 77. Asuragen Company Detail
Table 78. Asuragen Business Overview
Table 79. Asuragen Acute Lymphoblastic Testing Product
Table 80. Asuragen Revenue in Acute Lymphoblastic Testing Business (2018-2023) & (US$ Million)
Table 81. Asuragen Recent Development
Table 82. Adaptive Biotechnologies Company Detail
Table 83. Adaptive Biotechnologies Business Overview
Table 84. Adaptive Biotechnologies Acute Lymphoblastic Testing Product
Table 85. Adaptive Biotechnologies Revenue in Acute Lymphoblastic Testing Business (2018-2023) & (US$ Million)
Table 86. Adaptive Biotechnologies Recent Development
Table 87. NeoGenomics Lab Company Detail
Table 88. NeoGenomics Lab Business Overview
Table 89. NeoGenomics Lab Acute Lymphoblastic Testing Product
Table 90. NeoGenomics Lab Revenue in Acute Lymphoblastic Testing Business (2018-2023) & (US$ Million)
Table 91. NeoGenomics Lab Recent Development
Table 92. Laboratory Corporation of America Holdings Company Detail
Table 93. Laboratory Corporation of America Holdings Business Overview
Table 94. Laboratory Corporation of America Holdings Acute Lymphoblastic Testing Product
Table 95. Laboratory Corporation of America Holdings Revenue in Acute Lymphoblastic Testing Business (2018-2023) & (US$ Million)
Table 96. Laboratory Corporation of America Holdings Recent Development
Table 97. ARUP Lab Company Detail
Table 98. ARUP Lab Business Overview
Table 99. ARUP Lab Acute Lymphoblastic Testing Product
Table 100. ARUP Lab Revenue in Acute Lymphoblastic Testing Business (2018-2023) & (US$ Million)
Table 101. ARUP Lab Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Lymphoblastic Testing Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Acute Lymphoblastic Testing Market Share by Type: 2022 VS 2029
Figure 3. B lymphocytes Testing Features
Figure 4. T lymphocyte Testing Features
Figure 5. Others Features
Figure 6. Global Acute Lymphoblastic Testing Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Acute Lymphoblastic Testing Market Share by Application: 2022 VS 2029
Figure 8. Clinical Laboratories Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Academic and Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Acute Lymphoblastic Testing Report Years Considered
Figure 13. Global Acute Lymphoblastic Testing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Acute Lymphoblastic Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Acute Lymphoblastic Testing Market Share by Region: 2022 VS 2029
Figure 16. Global Acute Lymphoblastic Testing Market Share by Players in 2022
Figure 17. Global Top Acute Lymphoblastic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Lymphoblastic Testing as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Acute Lymphoblastic Testing Revenue in 2022
Figure 19. North America Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Acute Lymphoblastic Testing Market Share by Country (2018-2029)
Figure 21. United States Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Acute Lymphoblastic Testing Market Share by Country (2018-2029)
Figure 25. Germany Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Acute Lymphoblastic Testing Market Share by Region (2018-2029)
Figure 33. China Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Acute Lymphoblastic Testing Market Share by Country (2018-2029)
Figure 41. Mexico Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Acute Lymphoblastic Testing Market Share by Country (2018-2029)
Figure 45. Turkey Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Acute Lymphoblastic Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. DrLal Path Labs Revenue Growth Rate in Acute Lymphoblastic Testing Business (2018-2023)
Figure 48. Bio-Rad Lab Revenue Growth Rate in Acute Lymphoblastic Testing Business (2018-2023)
Figure 49. Qiagen Revenue Growth Rate in Acute Lymphoblastic Testing Business (2018-2023)
Figure 50. Invivoscribe Revenue Growth Rate in Acute Lymphoblastic Testing Business (2018-2023)
Figure 51. Illumina Revenue Growth Rate in Acute Lymphoblastic Testing Business (2018-2023)
Figure 52. ArcherDx Revenue Growth Rate in Acute Lymphoblastic Testing Business (2018-2023)
Figure 53. Asuragen Revenue Growth Rate in Acute Lymphoblastic Testing Business (2018-2023)
Figure 54. Adaptive Biotechnologies Revenue Growth Rate in Acute Lymphoblastic Testing Business (2018-2023)
Figure 55. NeoGenomics Lab Revenue Growth Rate in Acute Lymphoblastic Testing Business (2018-2023)
Figure 56. Laboratory Corporation of America Holdings Revenue Growth Rate in Acute Lymphoblastic Testing Business (2018-2023)
Figure 57. ARUP Lab Revenue Growth Rate in Acute Lymphoblastic Testing Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 急性骨髄性白血病（AML）バイオマーカー検査の世界市場2023年：遺伝性急性骨髄性白血病（AML）バイオマーカー、エピジェネティック急性骨髄性白血病（AML）バイオマーカー、プロテオーム性急性骨髄性白血病（AML）バイオマーカー
  • 薬物乱用試験サービスの世界市場2023年：尿、唾液、毛髪、その他
  • ベアボードテストの世界市場2023年：ピン固定試験、フライングプローブ試験
  • コンパートメント症候群圧力モニタリングの世界市場2023年：急性コンパートメント症候群、慢性コンパートメント症候群
  • 予防医療技術の世界市場2023年：遺伝子検査/スクリーニング、ワクチン
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7418 )"急性リンパ芽球検査の世界市場2023年：Bリンパ球検査、Tリンパ球検査、その他" (英文：Global Acute Lymphoblastic Testing Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。